aana glp 1 guidelines Patient Selection Criteria: Clinical Considerations for Elevated HBA1C by aanapublishing A Scoping Review of GLP-1

Obesity prevalence has doubled since 1990, with one in eight individuals being obese worldwide

Mol Metab 2024;85:101960.ArticlePubMedPMC 109

FuturHealths combination of no insurance requirements, predictable pricing, access to both compounded and branded GLP-1s, and real-time support positions it as one of the most user-friendly and efficient platforms available for prescription weight loss medication

Our Milwaukee-based medical weight loss programs are built on a foundation of safety, support, and genuine partnership

Primary discontinuation was defined as the first date a patient went 60 days or more without any GLP-1based treatment on hand, using fill dates and number of days of medication supplied to account for excess (carryover) medication from previous fills